Pricing Log in Create free account
Saturday 17 October 2026 Export TECH’s income statement to Excel — free account

Bio-Techne Corp

TECH Healthcare Biotechnology

Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025. In the quarter to June 2026, revenue grew 1.33%, EPS grew 418.2%, free cash flow fell 6.83% and total debt fell 42.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years.

72.54 0.02 +0.03%
Market cap
$11.4B
P/E
62.0×
Fwd P/E
37.6×
Dividend yield
0.44%
F-score
9/9
Altman Z
15.50
Beneish M
−2.52
Dividend safety
78/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bio-Techne Corp (TECH) Book value per share

Alert me on Book value per share

Bio-Techne Corp's book value per share at the end of fiscal 2026 was 13.5×, up 11.0% from 12.2× in fiscal 2025. Over the past ten years it has ranged from 5.7× (fiscal 2015) to 13.5× (fiscal 2026) — the current reading is the highest in ten years. Bio-Techne Corp ranks 52nd of 612 Biotechnology companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2026 13.5× 10.97%
FY2025 12.2× (7.14%)
FY2024 13.1× 4.85%
FY2023 12.5× 15.38%
FY2022 10.8× 6.96%
FY2021 10.1× 12.16%
FY2020 9.0× 17.19%
FY2019 7.7× 7.15%
FY2018 7.2× 13.13%
FY2017 6.4× 7.66%

Quarterly newest first

Period Book value per share Change
Jun 2026 13.5× 1.33%
Mar 2026 13.3× 3.37%
Dec 2025 12.9× 2.05%
Sep 2025 12.6× 3.81%
42 more quarters

Against its own ten years

Low 5.7× High 13.5×
Ten-year median 9.6×
Current reading's percentile 100

Book value per share against peers

Company Book value per share
KRYS Krystal Biotech, Inc. compare 46.0×
BMRN BioMarin Pharmaceutical Inc. compare 32.7×
PCVX Vaxcyte, Inc. compare 19.1×
MDGL Madrigal Pharmaceuticals, Inc. compare 18.0×
TECH Bio-Techne Corp 13.5×
CORT Corcept Therapeutics Incorporated compare 6.7×
SMMT Summit Therapeutics PLC compare 0.8×
IBRX ImmunityBio, Inc. compare −1.0×
BBIO BridgeBio Pharma, Inc. compare −12.8×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on TECH